Benzodiazepines in the Treatment of Anxiety
Abstract
In view of the conservative pattern of benzodiazepine use, its efficacy as a therapeutic alternative, and the relatively low incidence of tolerance and physical-dependence effects associated with benzodiazepine use in therapeutic doses, it is argued that the time has come to consider cost-benefit ratios when discussing the use of benzodiazepines for the treatment of anxiety.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
